Browsing by Subject "CITIM 2017"
Now showing items 1-1 of 1
-
(Springer Science and Business Media Deutschland GmbH, 2018)© 2018, The Author(s). Immunotherapy based on checkpoint blockers has proven survival benefits in patients with melanoma and other malignancies. Nevertheless, a significant proportion of treated patients remains refractory, ...